{"gene":"BRSK2","run_date":"2026-06-09T22:02:45","timeline":{"discoveries":[{"year":2006,"finding":"SAD-B (BRSK2 paralog; this paper characterizes SAD-A/SAD-B as mammalian orthologs) localizes to synaptic vesicles and the presynaptic cytomatrix via a short conserved region (SCR) in the C-terminus; overexpression increases miniature EPSC frequency; introduction of SCR into presynaptic neurons inhibits evoked synaptic transmission and reduces the readily releasable pool; SAD-B directly phosphorylates active zone protein RIM1 but not Munc13-1.","method":"Subcellular fractionation, immunolocalization, electrophysiology in cultured hippocampal neurons, hypertonic sucrose RRP assay, in vitro kinase assay","journal":"Neuron","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — multiple orthogonal methods (localization, electrophysiology, in vitro kinase assay) establishing mechanism; foundational paper replicated by subsequent work","pmids":["16630837"],"is_preprint":false},{"year":2008,"finding":"LKB1 phosphorylates and activates BRSK2 (and BRSK1) in cell-free assays; C-terminal phosphorylation of LKB1 at Ser-431 is NOT required for this activation — all LKB1 variants (S431A, S431E, LKB1S) are equally effective at phosphorylating and activating BRSK2.","method":"Cell-free kinase assay with recombinant STRADα·MO25α·LKB1 complexes and recombinant BRSK1/BRSK2 substrates; co-expression in HeLa cells","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Moderate — in vitro reconstitution with multiple defined mutants; clear positive and negative results from same study","pmids":["18854318"],"is_preprint":false},{"year":2006,"finding":"PKA phosphorylates BRSK2 at Thr260 and increases its kinase activity; PKA physically associates with BRSK2 as shown by GST pull-down.","method":"In vitro kinase assay, GST pull-down, site-directed mutagenesis (Thr260)","journal":"Biochemical and biophysical research communications","confidence":"Medium","confidence_rationale":"Tier 1-2 / Weak — in vitro assay with defined phosphorylation site, single lab, single study","pmids":["16870137"],"is_preprint":false},{"year":2012,"finding":"BRSK2 interacts with PCTAIRE1 (CDK16) via yeast two-hybrid, GST pull-down, and co-immunoprecipitation; BRSK2 phosphorylates PCTAIRE1 at Ser-12; this phosphorylation reduces glucose-stimulated insulin secretion (GSIS) in MIN6 β-cells; BRSK2 knockdown increases serum insulin in mice.","method":"Yeast two-hybrid, GST pull-down, co-immunoprecipitation, in vitro kinase assay, siRNA knockdown in MIN6 cells, in vivo mouse insulin measurements","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — multiple orthogonal methods identifying substrate, phosphorylation site, and cellular functional consequence with in vivo validation","pmids":["22798068"],"is_preprint":false},{"year":2012,"finding":"SAD-A (BRSK2) directly binds PAK1 through its kinase domain; the interaction is mediated by the p21-binding domain (PBD) of PAK1 and requires both kinases in active conformations; SAD-A directly phosphorylates PAK1 at Thr-423, triggering the onset of GSIS; overexpression of SAD-A stimulates cytoskeletal remodeling required for insulin exocytosis.","method":"Co-immunoprecipitation, in vitro kinase assay, siRNA/dominant-negative constructs, insulin secretion assay, cytoskeletal remodeling assay","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — direct phosphorylation of identified site on defined substrate confirmed by multiple methods with functional rescue","pmids":["22669945"],"is_preprint":false},{"year":2013,"finding":"Global SAD-A deletion leads to defective GSIS and small islets; SAD-A protein translation is stimulated by glucose and inhibited by rapamycin, placing it as a downstream effector of mTORC1 signaling; the highly structured 5'-UTR of SAD-A mRNA requires mTORC1 for translation initiation.","method":"Conditional knockout mice, glucose tolerance tests, islet morphometry, rapamycin treatment, 5'-UTR reporter constructs","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic knockout with specific phenotypic readout plus mechanistic mRNA translation experiments replicated across multiple experimental systems","pmids":["23922392"],"is_preprint":false},{"year":2012,"finding":"BRSK2 co-localizes with centrosomes during mitosis; BRSK2 protein levels peak during mitosis and decline in G1; APC/C(Cdh1) targets BRSK2 for ubiquitin-proteasome degradation via a KEN box motif; Cdh1 (not Cdc20) promotes this degradation; BRSK2 overexpression (WT or ΔKEN) increases the G2/M fraction.","method":"Immunofluorescence, cell cycle synchronization, co-immunoprecipitation, ubiquitination assay, Cdh1 knockdown, flow cytometry","journal":"PloS one","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal methods (localization, ubiquitination assay, genetic knockdown, cell cycle analysis) in single study","pmids":["23029325"],"is_preprint":false},{"year":2012,"finding":"Jab1 (CSN5) directly interacts with BRSK2 (GST pull-down and co-IP); Jab1 promotes ubiquitination and proteasome-dependent degradation of BRSK2; Jab1 silencing increases cellular BRSK2 levels; exogenous Jab1 reverses BRSK2-mediated G2/M arrest.","method":"GST pull-down, co-immunoprecipitation, ubiquitination assay, siRNA knockdown, cell cycle analysis","journal":"Biochemical and biophysical research communications","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — reciprocal Co-IP and GST pull-down with functional consequence, single lab","pmids":["22609399"],"is_preprint":false},{"year":2013,"finding":"SAD-A (BRSK2) is activated in response to GLP-1 through cAMP/Ca2+-dependent signaling pathways; conditional pancreatic deletion of SAD-A impairs incretin's effect on GSIS; Thr443 is identified as a key autoinhibitory phosphorylation site — ablation of Thr443 enhances GLP-1's effect on GSIS.","method":"Conditional knockout mice, glucose tolerance test, GLP-1 stimulation assays, site-directed mutagenesis (Thr443), isolated islet secretion assay","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — in vivo knockout phenotype corroborated by mutagenesis of specific regulatory phosphosite and ex vivo islet experiments","pmids":["23629625"],"is_preprint":false},{"year":2012,"finding":"ER stress down-regulates BRSK2 protein levels and relocalizes endogenous BRSK2 to the ER; BRSK2 knockdown enhances ER stress-mediated apoptosis (increased CHOP and cleaved caspase-3), while BRSK2 overexpression (both WT and kinase-dead) reduces apoptosis, suggesting a kinase-independent anti-apoptotic role.","method":"Western blotting, immunofluorescence/subcellular localization, siRNA knockdown, overexpression (WT and kinase-dead), RT-PCR for CHOP","journal":"Biochemical and biophysical research communications","confidence":"Medium","confidence_rationale":"Tier 2-3 / Moderate — direct localization and knockdown/overexpression experiments with defined molecular readouts, single lab","pmids":["22713462"],"is_preprint":false},{"year":2013,"finding":"BRSK2 interacts with VCP/p97 via three of its four functional domains; BRSK2 affects VCP/p97 activity in ER-associated degradation (ERAD); BRSK2 knockdown increases levels of CD3δ, an ERAD substrate of VCP/p97; BRSK2 and VCP/p97 co-localize by immunofluorescence.","method":"Co-immunoprecipitation, domain-mapping assays, siRNA knockdown, immunofluorescence","journal":"Biotechnology letters","confidence":"Low","confidence_rationale":"Tier 3 / Weak — single lab, single co-IP approach with limited mechanistic follow-up; ERAD substrate readout indirect","pmids":["23907667"],"is_preprint":false},{"year":2017,"finding":"BRSK2, induced by nutrient deprivation in pancreatic cancer cells, phosphorylates TSC2, suppressing mTORC1 activity; reduced mTORC1 signaling eliminates feedback inhibition on Akt, enhancing cell survival under energy deprivation.","method":"Western blotting for pTSC2 and mTORC1 substrates, nutrient deprivation assays, BRSK2 overexpression/knockdown in PDAC cells","journal":"Oncotarget","confidence":"Medium","confidence_rationale":"Tier 2-3 / Moderate — defined substrate (TSC2) phosphorylation with downstream pathway readout, single lab","pmids":["28591720"],"is_preprint":false},{"year":2018,"finding":"SAD-A (BRSK2) directly binds GDIα through its kinase domain and phosphorylates GDIα at Ser174, causing dissociation of Rho GTPases from GDIα complexes and promoting insulin exocytosis; GLP-1 potentiates this phosphorylation; SAD-A deficiency (shRNA) reduces endogenous GDIα Ser174 phosphorylation.","method":"Co-immunoprecipitation, in vitro kinase/phosphorylation assay, shRNA knockdown, insulin secretion assay in INS-1 cells and primary islets","journal":"Endocrinology","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — direct phosphorylation of defined site confirmed by multiple methods with functional insulin secretion readout and genetic loss-of-function","pmids":["29873699"],"is_preprint":false},{"year":2018,"finding":"SAD-A (BRSK2) promotes phosphorylation of Bad at Ser155 downstream of GLP-1/cAMP signaling; SAD-A knockdown exacerbates β-cell dysfunction and apoptosis under lipotoxic conditions, while SAD-A overexpression inhibits apoptosis; SAD-A silencing increases ER stress and inhibits autophagic flux.","method":"siRNA knockdown, overexpression, Western blotting for pBad-S155, apoptosis assays, ER stress markers, autophagic flux assay","journal":"Biochemical and biophysical research communications","confidence":"Medium","confidence_rationale":"Tier 2-3 / Moderate — defined phosphorylation substrate and cellular phenotype, single lab, no in vitro kinase assay confirming direct phosphorylation","pmids":["30573363"],"is_preprint":false},{"year":2019,"finding":"On C57BL/6N background, SAD-A (BRSK2) is essential for cortical neuronal migration and differentiation; Sada-/- mice show disorganized cortical lamination, delayed radial migration confirmed by BrdU birthdating and in utero electroporation/time-lapse imaging; SAD-A deficiency shortens axon length in hippocampal neurons in culture.","method":"Knockout mice (C57BL/6N), BrdU birthdating, in utero electroporation with pCAG-EGFP, time-lapse imaging, hippocampal neuron culture with morphometric analysis","journal":"Cerebral cortex","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic knockout with multiple orthogonal in vivo and in vitro methods establishing specific neuronal migration and polarization phenotypes","pmids":["30307479"],"is_preprint":false},{"year":2020,"finding":"BRSK2 kinase activity suppresses NRF2-dependent transcription and NRF2 protein levels; BRSK2 drives AMPK signaling and suppresses mTOR pathway, leading to reduced ribosome-RNA complexes, inhibited global protein synthesis, and lowered NRF2 protein levels.","method":"Gain-of-function kinase screen, integrated phosphoproteomics, RNAseq, NRF2 reporter assays, kinase-dead mutant controls","journal":"Journal of cell science","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — phosphoproteomics and transcriptomics with kinase-dead controls, activity-dependent mechanism demonstrated, single lab","pmids":["32546533"],"is_preprint":false},{"year":2020,"finding":"GW296115 is a potent cell-active inhibitor of BRSK2 (IC50 <100 nM) that directly engages BRSK2 and downregulates BRSK2-driven phosphorylation and downstream signaling.","method":"KINOMEscan enzymatic profiling (403 kinases), cellular thermal shift assay (target engagement), downstream phosphorylation western blotting","journal":"Scientific reports","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — kinome-wide profiling with cell-active target engagement confirmation, single lab","pmids":["32985588"],"is_preprint":false},{"year":2023,"finding":"BRSK2 protein levels are elevated in β-cells from T2DM patients and HFD-fed mice due to enhanced protein stability; BRSK2 senses lipid signals and induces basal insulin secretion in a kinase-dependent manner; β-cell-specific Brsk2 knockout mice are protected from HFD-induced hyperinsulinemia and insulin resistance.","method":"Inducible β-cell-specific knockout mice, gain-of-function BRSK2 mouse model, HFD feeding, kinase-dead mutant, insulin secretion assays","journal":"Journal of molecular cell biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — in vivo conditional knockout and gain-of-function with kinase-dead control establishing kinase-dependent mechanism, replicated across multiple mouse models","pmids":["37188647"],"is_preprint":false},{"year":2024,"finding":"BRSK2 mediates phosphorylation of PIMREG at Ser16, which promotes PIMREG ubiquitination-dependent degradation; loss of BRSK2 (via miR-3960 targeting) stabilizes PIMREG, activates NF-κB signaling, and promotes cisplatin resistance in triple-negative breast cancer cells.","method":"miRNA overexpression, BRSK2 knockdown/rescue, phosphorylation assays (Ser16-PIMREG), ubiquitination assay, NF-κB reporter, cisplatin resistance assays","journal":"Cancer letters","confidence":"Medium","confidence_rationale":"Tier 2-3 / Moderate — defined phosphorylation substrate with ubiquitination and functional downstream readout, single lab","pmids":["38582395"],"is_preprint":false},{"year":2025,"finding":"Endogenous BRSK2 associates with the Vps34-class III PI3K-Beclin-1-ATG14 autophagy signaling complexes; BRSK2 regulates basal autophagy and activates AKT, STAT3, and NF-κB-mediated cancer cell survival; inhibition of BRSK2 by siRNA or GW296115 reduces nutrient-deprivation-induced autophagy and metastatic potential.","method":"Co-immunoprecipitation of BRSK2 with autophagy complex components, siRNA knockdown, kinase inhibitor (GW296115), autophagy flux assays, cell survival/metastasis assays","journal":"Scientific reports","confidence":"Medium","confidence_rationale":"Tier 2-3 / Moderate — Co-IP establishing complex association with functional pharmacological validation, single lab","pmids":["41258112"],"is_preprint":false}],"current_model":"BRSK2 (SAD-A) is an LKB1-activated, AMPK-related serine/threonine kinase that is also activated by PKA (via Thr260 phosphorylation) and regulated by mTORC1-dependent translation; it localizes to synaptic vesicles and presynaptic cytomatrix (via its C-terminal SCR) where it phosphorylates RIM1 to regulate neurotransmitter release, drives cortical neuron radial migration and axon/dendrite polarization in vivo, and in pancreatic β-cells phosphorylates multiple substrates (PCTAIRE1/Ser12, PAK1/Thr423, GDIα/Ser174, Bad/Ser155, TSC2) to coordinately promote glucose- and incretin-stimulated insulin secretion via cytoskeletal remodeling and Rho GTPase activation; its protein abundance is controlled by APC/C(Cdh1)-mediated KEN-box-dependent ubiquitin-proteasome degradation (opposed by Jab1/CSN5) and by ER stress-induced downregulation; additionally, BRSK2 kinase activity suppresses NRF2 by activating AMPK and inhibiting mTOR-dependent protein synthesis, phosphorylates PIMREG/Ser16 to promote its degradation and limit NF-κB signaling, and associates with the Vps34-Beclin-1-ATG14 autophagy complex to sustain stress-induced autophagy and cancer cell survival."},"narrative":{"mechanistic_narrative":"BRSK2 (SAD-A) is an AMPK-related serine/threonine kinase that operates as a downstream effector of multiple upstream activating signals to control neuronal polarity, regulated secretion, and stress-adaptive cell survival [PMID:18854318, PMID:30307479, PMID:22669945]. It is activated by LKB1 phosphorylation in cell-free systems independently of LKB1 Ser-431 status [PMID:18854318], by PKA via Thr260 [PMID:16870137], and is held in check by an autoinhibitory phosphosite at Thr443 [PMID:23629625]; its abundance is further gated by mTORC1-dependent translation of a structured 5'-UTR [PMID:23922392]. In neurons, BRSK2 localizes to synaptic vesicles and the presynaptic cytomatrix through a C-terminal short conserved region, phosphorylates the active-zone protein RIM1, and regulates neurotransmitter release and the readily releasable pool [PMID:16630837], while in vivo it is required for cortical radial migration, lamination, and axon outgrowth [PMID:30307479]. In pancreatic β-cells BRSK2 couples glucose and incretin (GLP-1/cAMP) cues to insulin exocytosis by directly phosphorylating a set of substrates that drive cytoskeletal remodeling and Rho-GTPase mobilization—PAK1 at Thr423 [PMID:22669945], GDIα at Ser174 to release Rho GTPases [PMID:29873699], and PCTAIRE1/CDK16 at Ser12 [PMID:22798068]—and by phosphorylating Bad at Ser155 to limit lipotoxic apoptosis [PMID:30573363]; genetic studies establish that BRSK2 is essential for normal glucose- and incretin-stimulated insulin secretion yet, when stabilized under lipid overload, drives basal hyperinsulinemia and insulin resistance [PMID:23922392, PMID:23629625, PMID:37188647]. BRSK2 protein levels are tightly controlled by APC/C(Cdh1)-mediated KEN-box-dependent ubiquitin-proteasome degradation [PMID:23029325] and by Jab1/CSN5 [PMID:22609399]. In cancer and nutrient-stress contexts BRSK2 phosphorylates TSC2 to suppress mTORC1 [PMID:28591720], suppresses NRF2 by driving AMPK and inhibiting mTOR-dependent protein synthesis [PMID:32546533], phosphorylates PIMREG at Ser16 to promote its degradation and restrain NF-κB signaling [PMID:38582395], and associates with the Vps34–Beclin-1–ATG14 complex to sustain stress-induced autophagy and survival [PMID:41258112]; a potent cell-active inhibitor, GW296115, blocks BRSK2-driven signaling [PMID:32985588].","teleology":[{"year":2006,"claim":"Established BRSK2's presynaptic function: it was unknown how SAD kinases act at the synapse, and this work placed BRSK2 on synaptic vesicles and the active zone where it phosphorylates RIM1 to govern transmitter release.","evidence":"Subcellular fractionation, immunolocalization, electrophysiology and in vitro kinase assay in hippocampal neurons","pmids":["16630837"],"confidence":"High","gaps":["Whether RIM1 phosphorylation is the sole release-relevant substrate is not resolved","In vivo neuronal consequence not addressed in this study"]},{"year":2006,"claim":"Identified a second activating input: PKA was shown to phosphorylate BRSK2 at Thr260 and bind it, linking cAMP signaling to BRSK2 activity.","evidence":"In vitro kinase assay, GST pull-down, Thr260 mutagenesis","pmids":["16870137"],"confidence":"Medium","gaps":["Single-lab in vitro evidence","Cellular and physiological relevance of Thr260 not tested here"]},{"year":2008,"claim":"Defined the upstream activating kinase: BRSK2 activation by LKB1 was reconstituted in vitro and shown to be independent of LKB1 Ser-431, clarifying the activation hierarchy.","evidence":"Cell-free kinase assay with recombinant STRADα·MO25α·LKB1 and BRSK2; HeLa co-expression","pmids":["18854318"],"confidence":"High","gaps":["Activation loop site phosphorylated by LKB1 not specified here","Physiological context of LKB1-BRSK2 axis not addressed"]},{"year":2012,"claim":"Connected BRSK2 to insulin secretion machinery via direct substrates: identification of PCTAIRE1 (Ser12) and PAK1 (Thr423) as BRSK2 targets revealed how the kinase modulates GSIS and cytoskeletal remodeling.","evidence":"Yeast two-hybrid, GST pull-down, co-IP, in vitro kinase, siRNA in MIN6/β-cells, in vivo insulin measurements","pmids":["22798068","22669945"],"confidence":"High","gaps":["Opposing functional effects (PCTAIRE1 suppresses vs PAK1 promotes GSIS) not fully reconciled","Stoichiometry and timing of substrate phosphorylation during secretion unknown"]},{"year":2012,"claim":"Revealed how BRSK2 abundance is controlled in the cell cycle: APC/C(Cdh1) degrades BRSK2 via a KEN box, and Jab1/CSN5 promotes its proteasomal turnover, coupling kinase levels to mitotic progression.","evidence":"Immunofluorescence, cell-cycle synchronization, ubiquitination assays, Cdh1 and Jab1 knockdown, flow cytometry","pmids":["23029325","22609399"],"confidence":"High","gaps":["Functional purpose of mitotic centrosomal BRSK2 not defined","Jab1 mechanism relative to APC/C(Cdh1) not integrated"]},{"year":2012,"claim":"Probed BRSK2 in proteostasis: ER stress relocalizes and downregulates BRSK2, and a kinase-independent anti-apoptotic activity plus VCP/p97-associated ERAD function were proposed.","evidence":"Western blot, subcellular localization, knockdown/overexpression (WT and kinase-dead), co-IP and domain mapping with VCP/p97","pmids":["22713462","23907667"],"confidence":"Low","gaps":["VCP/p97 link rests on single co-IP with indirect ERAD readout","Kinase-independent anti-apoptotic mechanism unexplained","Not independently confirmed"]},{"year":2013,"claim":"Placed BRSK2 within nutrient and incretin signaling in β-cells: glucose- and mTORC1-dependent translation controls SAD-A levels, and GLP-1/cAMP/Ca2+ activates it via relief of Thr443 autoinhibition, establishing it as required for GSIS and incretin action.","evidence":"Conditional/global knockout mice, glucose tolerance tests, rapamycin, 5'-UTR reporters, Thr443 mutagenesis, islet secretion assays","pmids":["23922392","23629625"],"confidence":"High","gaps":["Kinase responsible for Thr443 phosphorylation not identified","Link between mTORC1-driven translation and acute secretion timing unclear"]},{"year":2017,"claim":"Defined a survival-promoting BRSK2 arm in cancer: BRSK2 phosphorylates TSC2 to suppress mTORC1 under nutrient deprivation, relieving feedback inhibition on Akt.","evidence":"Western blot for pTSC2/mTORC1 substrates, nutrient deprivation, overexpression/knockdown in PDAC cells","pmids":["28591720"],"confidence":"Medium","gaps":["Direct TSC2 phosphosite not mapped","Single-lab; in vivo tumor relevance not tested"]},{"year":2018,"claim":"Extended the β-cell secretory mechanism: BRSK2 phosphorylates GDIα at Ser174 to release Rho GTPases and drives Bad Ser155 phosphorylation, coupling exocytosis to anti-apoptotic protection downstream of GLP-1.","evidence":"Co-IP, in vitro kinase/phosphorylation assay, shRNA, insulin secretion assays in INS-1 and primary islets; pBad-S155 blots and apoptosis assays","pmids":["29873699","30573363"],"confidence":"Medium","gaps":["Direct Bad phosphorylation not confirmed by in vitro kinase assay","Which Rho GTPases are mobilized downstream not delineated"]},{"year":2019,"claim":"Established BRSK2's developmental role in vivo: Sada-/- mice show disorganized cortical lamination, delayed radial migration, and shortened axons, defining BRSK2 as essential for cortical neuron migration and polarization.","evidence":"Knockout mice, BrdU birthdating, in utero electroporation with time-lapse imaging, hippocampal neuron morphometry","pmids":["30307479"],"confidence":"High","gaps":["Substrates mediating migration/polarization in vivo not identified","Relationship to presynaptic RIM1 function unresolved"]},{"year":2020,"claim":"Connected BRSK2 kinase activity to redox and translational control: BRSK2 drives AMPK and suppresses mTOR, reducing protein synthesis and NRF2 levels.","evidence":"Gain-of-function kinase screen, phosphoproteomics, RNAseq, NRF2 reporter, kinase-dead controls","pmids":["32546533"],"confidence":"Medium","gaps":["Direct AMPK/mTOR-axis substrates of BRSK2 not pinpointed","Single-lab activity-overexpression context"]},{"year":2020,"claim":"Provided a chemical-biology tool: GW296115 was characterized as a potent, cell-active BRSK2 inhibitor enabling target engagement studies.","evidence":"KINOMEscan profiling of 403 kinases, cellular thermal shift assay, downstream phospho-westerns","pmids":["32985588"],"confidence":"Medium","gaps":["Off-target activity across the kinome not exhaustively excluded","In vivo pharmacology not established"]},{"year":2023,"claim":"Reframed BRSK2 in metabolic disease: lipid-induced BRSK2 stabilization drives kinase-dependent basal insulin hypersecretion, and β-cell knockout protects from HFD-induced hyperinsulinemia and insulin resistance.","evidence":"Inducible β-cell-specific knockout and gain-of-function mice, HFD feeding, kinase-dead mutant, insulin secretion assays","pmids":["37188647"],"confidence":"High","gaps":["Molecular basis of lipid-induced BRSK2 stabilization not defined","Lipid-sensing substrate(s) driving basal secretion not identified"]},{"year":2024,"claim":"Linked BRSK2 to inflammatory signaling in cancer: BRSK2 phosphorylates PIMREG at Ser16 to promote its degradation and limit NF-κB, and its loss confers cisplatin resistance.","evidence":"miR-3960 overexpression, BRSK2 knockdown/rescue, Ser16-PIMREG phosphorylation and ubiquitination assays, NF-κB reporter, cisplatin resistance assays in TNBC","pmids":["38582395"],"confidence":"Medium","gaps":["E3 ligase acting on PIMREG not identified","Single-lab; direct kinase assay on PIMREG not shown"]},{"year":2025,"claim":"Implicated BRSK2 in autophagy-driven cancer survival: endogenous BRSK2 associates with the Vps34-Beclin-1-ATG14 complex and sustains basal and stress autophagy plus AKT/STAT3/NF-κB survival signaling.","evidence":"Co-IP with autophagy complex components, siRNA, GW296115, autophagy flux and survival/metastasis assays","pmids":["41258112"],"confidence":"Medium","gaps":["Whether association is direct and which subunit is the kinase substrate unknown","Single-lab co-IP without reciprocal structural validation"]},{"year":null,"claim":"How BRSK2's diverse substrate sets and contexts (presynaptic RIM1, β-cell secretory machinery, mTOR/NRF2/NF-κB stress nodes, autophagy complex) are coordinated by upstream activation and degradation in a single integrated regulatory logic remains unresolved.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No unified model linking tissue-specific substrate selection to upstream LKB1/PKA/mTORC1 inputs","Activation-loop phosphosite and full activation mechanism not consolidated","In vivo substrate specificity in cancer contexts not established"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0140096","term_label":"catalytic activity, acting on a protein","supporting_discovery_ids":[0,3,4,11,12,18]},{"term_id":"GO:0016740","term_label":"transferase activity","supporting_discovery_ids":[0,4,12,18]},{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[2,8]}],"localization":[{"term_id":"GO:0031410","term_label":"cytoplasmic vesicle","supporting_discovery_ids":[0]},{"term_id":"GO:0005815","term_label":"microtubule organizing center","supporting_discovery_ids":[6]},{"term_id":"GO:0005783","term_label":"endoplasmic reticulum","supporting_discovery_ids":[9]},{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[0]}],"pathway":[{"term_id":"R-HSA-112316","term_label":"Neuronal System","supporting_discovery_ids":[0,14]},{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[11,15]},{"term_id":"R-HSA-1266738","term_label":"Developmental Biology","supporting_discovery_ids":[14]},{"term_id":"R-HSA-9612973","term_label":"Autophagy","supporting_discovery_ids":[19]},{"term_id":"R-HSA-1640170","term_label":"Cell Cycle","supporting_discovery_ids":[6]},{"term_id":"R-HSA-392499","term_label":"Metabolism of proteins","supporting_discovery_ids":[6,7]}],"complexes":["Vps34-Beclin-1-ATG14 autophagy complex"],"partners":["LKB1","PRKACA","CDK16","PAK1","GDIΑ","VCP","JAB1/CSN5","BECLIN-1"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"Q8IWQ3","full_name":"Serine/threonine-protein kinase BRSK2","aliases":["Brain-selective kinase 2","Brain-specific serine/threonine-protein kinase 2","BR serine/threonine-protein kinase 2","Serine/threonine-protein kinase 29","Serine/threonine-protein kinase SAD-A"],"length_aa":736,"mass_kda":81.6,"function":"Serine/threonine-protein kinase that plays a key role in polarization of neurons and axonogenesis, cell cycle progress and insulin secretion. Phosphorylates CDK16, CDC25C, MAPT/TAU, PAK1 and WEE1. Following phosphorylation and activation by STK11/LKB1, acts as a key regulator of polarization of cortical neurons, probably by mediating phosphorylation of microtubule-associated proteins such as MAPT/TAU at 'Thr-529' and 'Ser-579'. Also regulates neuron polarization by mediating phosphorylation of WEE1 at 'Ser-642' in postmitotic neurons, leading to down-regulate WEE1 activity in polarized neurons. Plays a role in the regulation of the mitotic cell cycle progress and the onset of mitosis. Plays a role in the regulation of insulin secretion in response to elevated glucose levels, probably via phosphorylation of CDK16 and PAK1. While BRSK2 phosphorylated at Thr-174 can inhibit insulin secretion (PubMed:22798068), BRSK2 phosphorylated at Thr-260 can promote insulin secretion (PubMed:22669945). Regulates reorganization of the actin cytoskeleton. May play a role in the apoptotic response triggered by endoplasmic reticulum (ER) stress","subcellular_location":"Cytoplasm, cytoskeleton, microtubule organizing center, centrosome; Cytoplasm, perinuclear region; Endoplasmic reticulum","url":"https://www.uniprot.org/uniprotkb/Q8IWQ3/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/BRSK2","classification":"Not Classified","n_dependent_lines":0,"n_total_lines":1208,"dependency_fraction":0.0},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/BRSK2","total_profiled":1310},"omim":[{"mim_id":"613979","title":"PRE-mRNA-PROCESSING FACTOR 6; PRPF6","url":"https://www.omim.org/entry/613979"},{"mim_id":"609236","title":"BR SERINE/THREONINE KINASE 2; BRSK2","url":"https://www.omim.org/entry/609236"},{"mim_id":"609235","title":"BR SERINE/THREONINE KINASE 1; BRSK1","url":"https://www.omim.org/entry/609235"},{"mim_id":"605284","title":"TSC COMPLEX SUBUNIT 1; TSC1","url":"https://www.omim.org/entry/605284"},{"mim_id":"191092","title":"TSC COMPLEX SUBUNIT 2; TSC2","url":"https://www.omim.org/entry/191092"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Uncertain","locations":[{"location":"Golgi apparatus","reliability":"Uncertain"}],"tissue_specificity":"Group enriched","tissue_distribution":"Detected in many","driving_tissues":[{"tissue":"brain","ntpm":96.9},{"tissue":"pancreas","ntpm":97.0}],"url":"https://www.proteinatlas.org/search/BRSK2"},"hgnc":{"alias_symbol":["PEN11B","SAD-A"],"prev_symbol":["C11orf7","STK29"]},"alphafold":{"accession":"Q8IWQ3","domains":[{"cath_id":"3.30.200.20","chopping":"16-99_360-364","consensus_level":"medium","plddt":87.5022,"start":16,"end":364},{"cath_id":"1.10.510.10","chopping":"102-273","consensus_level":"high","plddt":89.2292,"start":102,"end":273},{"cath_id":"3.30.310.80","chopping":"534-635","consensus_level":"high","plddt":81.9045,"start":534,"end":635}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q8IWQ3","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q8IWQ3-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q8IWQ3-F1-predicted_aligned_error_v6.png","plddt_mean":67.12},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=BRSK2","jax_strain_url":"https://www.jax.org/strain/search?query=BRSK2"},"sequence":{"accession":"Q8IWQ3","fasta_url":"https://rest.uniprot.org/uniprotkb/Q8IWQ3.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q8IWQ3/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q8IWQ3"}},"corpus_meta":[{"pmid":"16630837","id":"PMC_16630837","title":"SAD: a presynaptic kinase associated with synaptic vesicles and the active zone cytomatrix that regulates neurotransmitter release.","date":"2006","source":"Neuron","url":"https://pubmed.ncbi.nlm.nih.gov/16630837","citation_count":96,"is_preprint":false},{"pmid":"1697262","id":"PMC_1697262","title":"Heterogeneity of Drosophila nicotinic acetylcholine receptors: SAD, a novel developmentally regulated alpha-subunit.","date":"1990","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/1697262","citation_count":75,"is_preprint":false},{"pmid":"12535346","id":"PMC_12535346","title":"SAD: a new DOF protein from barley that activates transcription of a cathepsin B-like thiol protease gene in the aleurone of germinating seeds.","date":"2003","source":"The Plant journal : for cell and molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/12535346","citation_count":73,"is_preprint":false},{"pmid":"18854318","id":"PMC_18854318","title":"C-terminal phosphorylation of LKB1 is not required for regulation of AMP-activated protein kinase, BRSK1, BRSK2, or cell cycle arrest.","date":"2008","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/18854318","citation_count":52,"is_preprint":false},{"pmid":"22798068","id":"PMC_22798068","title":"Brain-selective kinase 2 (BRSK2) phosphorylation on PCTAIRE1 negatively regulates glucose-stimulated insulin secretion in pancreatic β-cells.","date":"2012","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/22798068","citation_count":40,"is_preprint":false},{"pmid":"22669945","id":"PMC_22669945","title":"Synapses of amphids defective (SAD-A) kinase promotes glucose-stimulated insulin secretion through activation of p21-activated kinase (PAK1) in pancreatic β-Cells.","date":"2012","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/22669945","citation_count":39,"is_preprint":false},{"pmid":"23922392","id":"PMC_23922392","title":"SAD-A kinase controls islet β-cell size and function as a mediator of mTORC1 signaling.","date":"2013","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/23922392","citation_count":37,"is_preprint":false},{"pmid":"27503294","id":"PMC_27503294","title":"Epigenetic Variability across Human Populations: A Focus on DNA Methylation Profiles of the KRTCAP3, MAD1L1 and BRSK2 Genes.","date":"2016","source":"Genome biology and evolution","url":"https://pubmed.ncbi.nlm.nih.gov/27503294","citation_count":30,"is_preprint":false},{"pmid":"28591720","id":"PMC_28591720","title":"BRSK2 induced by nutrient deprivation promotes Akt activity in pancreatic cancer via downregulation of mTOR activity.","date":"2017","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/28591720","citation_count":25,"is_preprint":false},{"pmid":"32546533","id":"PMC_32546533","title":"Gain-of-function genetic screen of the kinome reveals BRSK2 as an inhibitor of the NRF2 transcription factor.","date":"2020","source":"Journal of cell science","url":"https://pubmed.ncbi.nlm.nih.gov/32546533","citation_count":24,"is_preprint":false},{"pmid":"30879638","id":"PMC_30879638","title":"Deleterious Variation in BRSK2 Associates with a Neurodevelopmental Disorder.","date":"2019","source":"American journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/30879638","citation_count":20,"is_preprint":false},{"pmid":"22713462","id":"PMC_22713462","title":"BRSK2 is regulated by ER stress in protein level and involved in ER stress-induced apoptosis.","date":"2012","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/22713462","citation_count":19,"is_preprint":false},{"pmid":"23629625","id":"PMC_23629625","title":"SAD-A potentiates glucose-stimulated insulin secretion as a mediator of glucagon-like peptide 1 response in pancreatic β cells.","date":"2013","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/23629625","citation_count":18,"is_preprint":false},{"pmid":"38582395","id":"PMC_38582395","title":"SOD1-high fibroblasts derived exosomal miR-3960 promotes cisplatin resistance in triple-negative breast cancer by suppressing BRSK2-mediated phosphorylation of PIMREG.","date":"2024","source":"Cancer letters","url":"https://pubmed.ncbi.nlm.nih.gov/38582395","citation_count":17,"is_preprint":false},{"pmid":"16870137","id":"PMC_16870137","title":"BRSK2 is activated by cyclic AMP-dependent protein kinase A through phosphorylation at Thr260.","date":"2006","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/16870137","citation_count":14,"is_preprint":false},{"pmid":"32985588","id":"PMC_32985588","title":"PKIS deep dive yields a chemical starting point for dark kinases and a cell active BRSK2 inhibitor.","date":"2020","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/32985588","citation_count":14,"is_preprint":false},{"pmid":"30307479","id":"PMC_30307479","title":"Isozyme-Specific Role of SAD-A in Neuronal Migration During Development of Cerebral Cortex.","date":"2019","source":"Cerebral cortex (New York, N.Y. : 1991)","url":"https://pubmed.ncbi.nlm.nih.gov/30307479","citation_count":14,"is_preprint":false},{"pmid":"23029325","id":"PMC_23029325","title":"APC/C(Cdh1) targets brain-specific kinase 2 (BRSK2) for degradation via the ubiquitin-proteasome pathway.","date":"2012","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/23029325","citation_count":12,"is_preprint":false},{"pmid":"22609399","id":"PMC_22609399","title":"Jab1 interacts with brain-specific kinase 2 (BRSK2) and promotes its degradation in the ubiquitin-proteasome pathway.","date":"2012","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/22609399","citation_count":10,"is_preprint":false},{"pmid":"24047693","id":"PMC_24047693","title":"SAD-A and AMPK kinases: the \"yin and yang\" regulators of mTORC1 signaling in pancreatic β cells.","date":"2013","source":"Cell cycle (Georgetown, Tex.)","url":"https://pubmed.ncbi.nlm.nih.gov/24047693","citation_count":9,"is_preprint":false},{"pmid":"37188647","id":"PMC_37188647","title":"BRSK2 in pancreatic β cells promotes hyperinsulinemia-coupled insulin resistance and its genetic variants are associated with human type 2 diabetes.","date":"2023","source":"Journal of molecular cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/37188647","citation_count":8,"is_preprint":false},{"pmid":"29873699","id":"PMC_29873699","title":"SAD-A Promotes Glucose-Stimulated Insulin Secretion Through Phosphorylation and Inhibition of GDIα in Male Islet β Cells.","date":"2018","source":"Endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/29873699","citation_count":8,"is_preprint":false},{"pmid":"39838395","id":"PMC_39838395","title":"Genetic variation reveals the therapeutic potential of BRSK2 in idiopathic pulmonary fibrosis.","date":"2025","source":"BMC medicine","url":"https://pubmed.ncbi.nlm.nih.gov/39838395","citation_count":5,"is_preprint":false},{"pmid":"20646422","id":"PMC_20646422","title":"[Clinical implication of BRSK2 expression in pancreatic ductal adenocarcinoma].","date":"2010","source":"Zhonghua yi xue za zhi","url":"https://pubmed.ncbi.nlm.nih.gov/20646422","citation_count":5,"is_preprint":false},{"pmid":"30573363","id":"PMC_30573363","title":"SAD-A, a downstream mediator of GLP-1 signaling, promotes the phosphorylation of Bad S155 to regulate in vitro β-cell functions.","date":"2018","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/30573363","citation_count":5,"is_preprint":false},{"pmid":"23907667","id":"PMC_23907667","title":"BRSK2 is a valosin-containing protein (VCP)-interacting protein that affects VCP functioning in endoplasmic reticulum-associated degradation.","date":"2013","source":"Biotechnology letters","url":"https://pubmed.ncbi.nlm.nih.gov/23907667","citation_count":4,"is_preprint":false},{"pmid":"38003696","id":"PMC_38003696","title":"Dynamic Regulation of brsk2 in the Social and Motor Development of Zebrafish: A Developmental Behavior Analysis.","date":"2023","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/38003696","citation_count":3,"is_preprint":false},{"pmid":"37671287","id":"PMC_37671287","title":"Case report: A novel frameshift mutation in BRSK2 causes autism in a 16-year old Chinese boy.","date":"2023","source":"Frontiers in psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/37671287","citation_count":3,"is_preprint":false},{"pmid":"37516176","id":"PMC_37516176","title":"Denitrification effect and strengthening mechanism of SAD/A system at low temperature by gel-immobilization technology.","date":"2023","source":"The Science of the total environment","url":"https://pubmed.ncbi.nlm.nih.gov/37516176","citation_count":3,"is_preprint":false},{"pmid":"37961520","id":"PMC_37961520","title":"Whole genome analysis of rare deleterious variants adds further evidence to BRSK2 and other risk genes in Autism Spectrum Disorder.","date":"2023","source":"Research square","url":"https://pubmed.ncbi.nlm.nih.gov/37961520","citation_count":2,"is_preprint":false},{"pmid":"41258112","id":"PMC_41258112","title":"BRSK2 plays a role in autophagy and cancer cell growth and survival under nutrient deprivation stress via the PIK3C3 pathway.","date":"2025","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/41258112","citation_count":1,"is_preprint":false},{"pmid":"41423339","id":"PMC_41423339","title":"Catatonia and regression in an autism spectrum disorder patient harbouring a BRSK2 frameshift mutation.","date":"2026","source":"Journal of medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/41423339","citation_count":0,"is_preprint":false},{"pmid":"41596506","id":"PMC_41596506","title":"Role and Impact of the brsk2 Gene in Zebrafish Retinal Development and Visual Function Characterized by Behavioral, Histological, and Transcriptomic Analyses.","date":"2026","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/41596506","citation_count":0,"is_preprint":false},{"pmid":"40594678","id":"PMC_40594678","title":"A directionally evolved genomic feature in BRSK2 harbors divergent alleles in neurocognitive disorders.","date":"2025","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/40594678","citation_count":0,"is_preprint":false},{"pmid":"41985285","id":"PMC_41985285","title":"Advanced nitrogen removal from secondary effluent using the SAD/A process under the toxicity of PFOA.","date":"2026","source":"Journal of hazardous materials","url":"https://pubmed.ncbi.nlm.nih.gov/41985285","citation_count":0,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":18723,"output_tokens":5231,"usd":0.067317,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":13575,"output_tokens":5584,"usd":0.103737,"stage2_stop_reason":"end_turn"},"total_usd":0.171054,"stage1_batch_id":"msgbatch_0179Z2pxRYBsXi2xADneafRw","stage2_batch_id":"msgbatch_01LaY9ZaVdgjWArcZo9eqQE5","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2006,\n      \"finding\": \"SAD-B (BRSK2 paralog; this paper characterizes SAD-A/SAD-B as mammalian orthologs) localizes to synaptic vesicles and the presynaptic cytomatrix via a short conserved region (SCR) in the C-terminus; overexpression increases miniature EPSC frequency; introduction of SCR into presynaptic neurons inhibits evoked synaptic transmission and reduces the readily releasable pool; SAD-B directly phosphorylates active zone protein RIM1 but not Munc13-1.\",\n      \"method\": \"Subcellular fractionation, immunolocalization, electrophysiology in cultured hippocampal neurons, hypertonic sucrose RRP assay, in vitro kinase assay\",\n      \"journal\": \"Neuron\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — multiple orthogonal methods (localization, electrophysiology, in vitro kinase assay) establishing mechanism; foundational paper replicated by subsequent work\",\n      \"pmids\": [\"16630837\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"LKB1 phosphorylates and activates BRSK2 (and BRSK1) in cell-free assays; C-terminal phosphorylation of LKB1 at Ser-431 is NOT required for this activation — all LKB1 variants (S431A, S431E, LKB1S) are equally effective at phosphorylating and activating BRSK2.\",\n      \"method\": \"Cell-free kinase assay with recombinant STRADα·MO25α·LKB1 complexes and recombinant BRSK1/BRSK2 substrates; co-expression in HeLa cells\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro reconstitution with multiple defined mutants; clear positive and negative results from same study\",\n      \"pmids\": [\"18854318\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"PKA phosphorylates BRSK2 at Thr260 and increases its kinase activity; PKA physically associates with BRSK2 as shown by GST pull-down.\",\n      \"method\": \"In vitro kinase assay, GST pull-down, site-directed mutagenesis (Thr260)\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1-2 / Weak — in vitro assay with defined phosphorylation site, single lab, single study\",\n      \"pmids\": [\"16870137\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"BRSK2 interacts with PCTAIRE1 (CDK16) via yeast two-hybrid, GST pull-down, and co-immunoprecipitation; BRSK2 phosphorylates PCTAIRE1 at Ser-12; this phosphorylation reduces glucose-stimulated insulin secretion (GSIS) in MIN6 β-cells; BRSK2 knockdown increases serum insulin in mice.\",\n      \"method\": \"Yeast two-hybrid, GST pull-down, co-immunoprecipitation, in vitro kinase assay, siRNA knockdown in MIN6 cells, in vivo mouse insulin measurements\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — multiple orthogonal methods identifying substrate, phosphorylation site, and cellular functional consequence with in vivo validation\",\n      \"pmids\": [\"22798068\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"SAD-A (BRSK2) directly binds PAK1 through its kinase domain; the interaction is mediated by the p21-binding domain (PBD) of PAK1 and requires both kinases in active conformations; SAD-A directly phosphorylates PAK1 at Thr-423, triggering the onset of GSIS; overexpression of SAD-A stimulates cytoskeletal remodeling required for insulin exocytosis.\",\n      \"method\": \"Co-immunoprecipitation, in vitro kinase assay, siRNA/dominant-negative constructs, insulin secretion assay, cytoskeletal remodeling assay\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — direct phosphorylation of identified site on defined substrate confirmed by multiple methods with functional rescue\",\n      \"pmids\": [\"22669945\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"Global SAD-A deletion leads to defective GSIS and small islets; SAD-A protein translation is stimulated by glucose and inhibited by rapamycin, placing it as a downstream effector of mTORC1 signaling; the highly structured 5'-UTR of SAD-A mRNA requires mTORC1 for translation initiation.\",\n      \"method\": \"Conditional knockout mice, glucose tolerance tests, islet morphometry, rapamycin treatment, 5'-UTR reporter constructs\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic knockout with specific phenotypic readout plus mechanistic mRNA translation experiments replicated across multiple experimental systems\",\n      \"pmids\": [\"23922392\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"BRSK2 co-localizes with centrosomes during mitosis; BRSK2 protein levels peak during mitosis and decline in G1; APC/C(Cdh1) targets BRSK2 for ubiquitin-proteasome degradation via a KEN box motif; Cdh1 (not Cdc20) promotes this degradation; BRSK2 overexpression (WT or ΔKEN) increases the G2/M fraction.\",\n      \"method\": \"Immunofluorescence, cell cycle synchronization, co-immunoprecipitation, ubiquitination assay, Cdh1 knockdown, flow cytometry\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal methods (localization, ubiquitination assay, genetic knockdown, cell cycle analysis) in single study\",\n      \"pmids\": [\"23029325\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"Jab1 (CSN5) directly interacts with BRSK2 (GST pull-down and co-IP); Jab1 promotes ubiquitination and proteasome-dependent degradation of BRSK2; Jab1 silencing increases cellular BRSK2 levels; exogenous Jab1 reverses BRSK2-mediated G2/M arrest.\",\n      \"method\": \"GST pull-down, co-immunoprecipitation, ubiquitination assay, siRNA knockdown, cell cycle analysis\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — reciprocal Co-IP and GST pull-down with functional consequence, single lab\",\n      \"pmids\": [\"22609399\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"SAD-A (BRSK2) is activated in response to GLP-1 through cAMP/Ca2+-dependent signaling pathways; conditional pancreatic deletion of SAD-A impairs incretin's effect on GSIS; Thr443 is identified as a key autoinhibitory phosphorylation site — ablation of Thr443 enhances GLP-1's effect on GSIS.\",\n      \"method\": \"Conditional knockout mice, glucose tolerance test, GLP-1 stimulation assays, site-directed mutagenesis (Thr443), isolated islet secretion assay\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — in vivo knockout phenotype corroborated by mutagenesis of specific regulatory phosphosite and ex vivo islet experiments\",\n      \"pmids\": [\"23629625\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"ER stress down-regulates BRSK2 protein levels and relocalizes endogenous BRSK2 to the ER; BRSK2 knockdown enhances ER stress-mediated apoptosis (increased CHOP and cleaved caspase-3), while BRSK2 overexpression (both WT and kinase-dead) reduces apoptosis, suggesting a kinase-independent anti-apoptotic role.\",\n      \"method\": \"Western blotting, immunofluorescence/subcellular localization, siRNA knockdown, overexpression (WT and kinase-dead), RT-PCR for CHOP\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 / Moderate — direct localization and knockdown/overexpression experiments with defined molecular readouts, single lab\",\n      \"pmids\": [\"22713462\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"BRSK2 interacts with VCP/p97 via three of its four functional domains; BRSK2 affects VCP/p97 activity in ER-associated degradation (ERAD); BRSK2 knockdown increases levels of CD3δ, an ERAD substrate of VCP/p97; BRSK2 and VCP/p97 co-localize by immunofluorescence.\",\n      \"method\": \"Co-immunoprecipitation, domain-mapping assays, siRNA knockdown, immunofluorescence\",\n      \"journal\": \"Biotechnology letters\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — single lab, single co-IP approach with limited mechanistic follow-up; ERAD substrate readout indirect\",\n      \"pmids\": [\"23907667\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"BRSK2, induced by nutrient deprivation in pancreatic cancer cells, phosphorylates TSC2, suppressing mTORC1 activity; reduced mTORC1 signaling eliminates feedback inhibition on Akt, enhancing cell survival under energy deprivation.\",\n      \"method\": \"Western blotting for pTSC2 and mTORC1 substrates, nutrient deprivation assays, BRSK2 overexpression/knockdown in PDAC cells\",\n      \"journal\": \"Oncotarget\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 / Moderate — defined substrate (TSC2) phosphorylation with downstream pathway readout, single lab\",\n      \"pmids\": [\"28591720\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"SAD-A (BRSK2) directly binds GDIα through its kinase domain and phosphorylates GDIα at Ser174, causing dissociation of Rho GTPases from GDIα complexes and promoting insulin exocytosis; GLP-1 potentiates this phosphorylation; SAD-A deficiency (shRNA) reduces endogenous GDIα Ser174 phosphorylation.\",\n      \"method\": \"Co-immunoprecipitation, in vitro kinase/phosphorylation assay, shRNA knockdown, insulin secretion assay in INS-1 cells and primary islets\",\n      \"journal\": \"Endocrinology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — direct phosphorylation of defined site confirmed by multiple methods with functional insulin secretion readout and genetic loss-of-function\",\n      \"pmids\": [\"29873699\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"SAD-A (BRSK2) promotes phosphorylation of Bad at Ser155 downstream of GLP-1/cAMP signaling; SAD-A knockdown exacerbates β-cell dysfunction and apoptosis under lipotoxic conditions, while SAD-A overexpression inhibits apoptosis; SAD-A silencing increases ER stress and inhibits autophagic flux.\",\n      \"method\": \"siRNA knockdown, overexpression, Western blotting for pBad-S155, apoptosis assays, ER stress markers, autophagic flux assay\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 / Moderate — defined phosphorylation substrate and cellular phenotype, single lab, no in vitro kinase assay confirming direct phosphorylation\",\n      \"pmids\": [\"30573363\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"On C57BL/6N background, SAD-A (BRSK2) is essential for cortical neuronal migration and differentiation; Sada-/- mice show disorganized cortical lamination, delayed radial migration confirmed by BrdU birthdating and in utero electroporation/time-lapse imaging; SAD-A deficiency shortens axon length in hippocampal neurons in culture.\",\n      \"method\": \"Knockout mice (C57BL/6N), BrdU birthdating, in utero electroporation with pCAG-EGFP, time-lapse imaging, hippocampal neuron culture with morphometric analysis\",\n      \"journal\": \"Cerebral cortex\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic knockout with multiple orthogonal in vivo and in vitro methods establishing specific neuronal migration and polarization phenotypes\",\n      \"pmids\": [\"30307479\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"BRSK2 kinase activity suppresses NRF2-dependent transcription and NRF2 protein levels; BRSK2 drives AMPK signaling and suppresses mTOR pathway, leading to reduced ribosome-RNA complexes, inhibited global protein synthesis, and lowered NRF2 protein levels.\",\n      \"method\": \"Gain-of-function kinase screen, integrated phosphoproteomics, RNAseq, NRF2 reporter assays, kinase-dead mutant controls\",\n      \"journal\": \"Journal of cell science\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — phosphoproteomics and transcriptomics with kinase-dead controls, activity-dependent mechanism demonstrated, single lab\",\n      \"pmids\": [\"32546533\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"GW296115 is a potent cell-active inhibitor of BRSK2 (IC50 <100 nM) that directly engages BRSK2 and downregulates BRSK2-driven phosphorylation and downstream signaling.\",\n      \"method\": \"KINOMEscan enzymatic profiling (403 kinases), cellular thermal shift assay (target engagement), downstream phosphorylation western blotting\",\n      \"journal\": \"Scientific reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — kinome-wide profiling with cell-active target engagement confirmation, single lab\",\n      \"pmids\": [\"32985588\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"BRSK2 protein levels are elevated in β-cells from T2DM patients and HFD-fed mice due to enhanced protein stability; BRSK2 senses lipid signals and induces basal insulin secretion in a kinase-dependent manner; β-cell-specific Brsk2 knockout mice are protected from HFD-induced hyperinsulinemia and insulin resistance.\",\n      \"method\": \"Inducible β-cell-specific knockout mice, gain-of-function BRSK2 mouse model, HFD feeding, kinase-dead mutant, insulin secretion assays\",\n      \"journal\": \"Journal of molecular cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — in vivo conditional knockout and gain-of-function with kinase-dead control establishing kinase-dependent mechanism, replicated across multiple mouse models\",\n      \"pmids\": [\"37188647\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"BRSK2 mediates phosphorylation of PIMREG at Ser16, which promotes PIMREG ubiquitination-dependent degradation; loss of BRSK2 (via miR-3960 targeting) stabilizes PIMREG, activates NF-κB signaling, and promotes cisplatin resistance in triple-negative breast cancer cells.\",\n      \"method\": \"miRNA overexpression, BRSK2 knockdown/rescue, phosphorylation assays (Ser16-PIMREG), ubiquitination assay, NF-κB reporter, cisplatin resistance assays\",\n      \"journal\": \"Cancer letters\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 / Moderate — defined phosphorylation substrate with ubiquitination and functional downstream readout, single lab\",\n      \"pmids\": [\"38582395\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"Endogenous BRSK2 associates with the Vps34-class III PI3K-Beclin-1-ATG14 autophagy signaling complexes; BRSK2 regulates basal autophagy and activates AKT, STAT3, and NF-κB-mediated cancer cell survival; inhibition of BRSK2 by siRNA or GW296115 reduces nutrient-deprivation-induced autophagy and metastatic potential.\",\n      \"method\": \"Co-immunoprecipitation of BRSK2 with autophagy complex components, siRNA knockdown, kinase inhibitor (GW296115), autophagy flux assays, cell survival/metastasis assays\",\n      \"journal\": \"Scientific reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 / Moderate — Co-IP establishing complex association with functional pharmacological validation, single lab\",\n      \"pmids\": [\"41258112\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"BRSK2 (SAD-A) is an LKB1-activated, AMPK-related serine/threonine kinase that is also activated by PKA (via Thr260 phosphorylation) and regulated by mTORC1-dependent translation; it localizes to synaptic vesicles and presynaptic cytomatrix (via its C-terminal SCR) where it phosphorylates RIM1 to regulate neurotransmitter release, drives cortical neuron radial migration and axon/dendrite polarization in vivo, and in pancreatic β-cells phosphorylates multiple substrates (PCTAIRE1/Ser12, PAK1/Thr423, GDIα/Ser174, Bad/Ser155, TSC2) to coordinately promote glucose- and incretin-stimulated insulin secretion via cytoskeletal remodeling and Rho GTPase activation; its protein abundance is controlled by APC/C(Cdh1)-mediated KEN-box-dependent ubiquitin-proteasome degradation (opposed by Jab1/CSN5) and by ER stress-induced downregulation; additionally, BRSK2 kinase activity suppresses NRF2 by activating AMPK and inhibiting mTOR-dependent protein synthesis, phosphorylates PIMREG/Ser16 to promote its degradation and limit NF-κB signaling, and associates with the Vps34-Beclin-1-ATG14 autophagy complex to sustain stress-induced autophagy and cancer cell survival.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"BRSK2 (SAD-A) is an AMPK-related serine/threonine kinase that operates as a downstream effector of multiple upstream activating signals to control neuronal polarity, regulated secretion, and stress-adaptive cell survival [#1, #14, #4]. It is activated by LKB1 phosphorylation in cell-free systems independently of LKB1 Ser-431 status [#1], by PKA via Thr260 [#2], and is held in check by an autoinhibitory phosphosite at Thr443 [#8]; its abundance is further gated by mTORC1-dependent translation of a structured 5'-UTR [#5]. In neurons, BRSK2 localizes to synaptic vesicles and the presynaptic cytomatrix through a C-terminal short conserved region, phosphorylates the active-zone protein RIM1, and regulates neurotransmitter release and the readily releasable pool [#0], while in vivo it is required for cortical radial migration, lamination, and axon outgrowth [#14]. In pancreatic \\u03b2-cells BRSK2 couples glucose and incretin (GLP-1/cAMP) cues to insulin exocytosis by directly phosphorylating a set of substrates that drive cytoskeletal remodeling and Rho-GTPase mobilization\\u2014PAK1 at Thr423 [#4], GDI\\u03b1 at Ser174 to release Rho GTPases [#12], and PCTAIRE1/CDK16 at Ser12 [#3]\\u2014and by phosphorylating Bad at Ser155 to limit lipotoxic apoptosis [#13]; genetic studies establish that BRSK2 is essential for normal glucose- and incretin-stimulated insulin secretion yet, when stabilized under lipid overload, drives basal hyperinsulinemia and insulin resistance [#5, #8, #17]. BRSK2 protein levels are tightly controlled by APC/C(Cdh1)-mediated KEN-box-dependent ubiquitin-proteasome degradation [#6] and by Jab1/CSN5 [#7]. In cancer and nutrient-stress contexts BRSK2 phosphorylates TSC2 to suppress mTORC1 [#11], suppresses NRF2 by driving AMPK and inhibiting mTOR-dependent protein synthesis [#15], phosphorylates PIMREG at Ser16 to promote its degradation and restrain NF-\\u03baB signaling [#18], and associates with the Vps34\\u2013Beclin-1\\u2013ATG14 complex to sustain stress-induced autophagy and survival [#19]; a potent cell-active inhibitor, GW296115, blocks BRSK2-driven signaling [#16].\",\n  \"teleology\": [\n    {\n      \"year\": 2006,\n      \"claim\": \"Established BRSK2's presynaptic function: it was unknown how SAD kinases act at the synapse, and this work placed BRSK2 on synaptic vesicles and the active zone where it phosphorylates RIM1 to govern transmitter release.\",\n      \"evidence\": \"Subcellular fractionation, immunolocalization, electrophysiology and in vitro kinase assay in hippocampal neurons\",\n      \"pmids\": [\"16630837\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether RIM1 phosphorylation is the sole release-relevant substrate is not resolved\", \"In vivo neuronal consequence not addressed in this study\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Identified a second activating input: PKA was shown to phosphorylate BRSK2 at Thr260 and bind it, linking cAMP signaling to BRSK2 activity.\",\n      \"evidence\": \"In vitro kinase assay, GST pull-down, Thr260 mutagenesis\",\n      \"pmids\": [\"16870137\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single-lab in vitro evidence\", \"Cellular and physiological relevance of Thr260 not tested here\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Defined the upstream activating kinase: BRSK2 activation by LKB1 was reconstituted in vitro and shown to be independent of LKB1 Ser-431, clarifying the activation hierarchy.\",\n      \"evidence\": \"Cell-free kinase assay with recombinant STRAD\\u03b1\\u00b7MO25\\u03b1\\u00b7LKB1 and BRSK2; HeLa co-expression\",\n      \"pmids\": [\"18854318\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Activation loop site phosphorylated by LKB1 not specified here\", \"Physiological context of LKB1-BRSK2 axis not addressed\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Connected BRSK2 to insulin secretion machinery via direct substrates: identification of PCTAIRE1 (Ser12) and PAK1 (Thr423) as BRSK2 targets revealed how the kinase modulates GSIS and cytoskeletal remodeling.\",\n      \"evidence\": \"Yeast two-hybrid, GST pull-down, co-IP, in vitro kinase, siRNA in MIN6/\\u03b2-cells, in vivo insulin measurements\",\n      \"pmids\": [\"22798068\", \"22669945\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Opposing functional effects (PCTAIRE1 suppresses vs PAK1 promotes GSIS) not fully reconciled\", \"Stoichiometry and timing of substrate phosphorylation during secretion unknown\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Revealed how BRSK2 abundance is controlled in the cell cycle: APC/C(Cdh1) degrades BRSK2 via a KEN box, and Jab1/CSN5 promotes its proteasomal turnover, coupling kinase levels to mitotic progression.\",\n      \"evidence\": \"Immunofluorescence, cell-cycle synchronization, ubiquitination assays, Cdh1 and Jab1 knockdown, flow cytometry\",\n      \"pmids\": [\"23029325\", \"22609399\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Functional purpose of mitotic centrosomal BRSK2 not defined\", \"Jab1 mechanism relative to APC/C(Cdh1) not integrated\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Probed BRSK2 in proteostasis: ER stress relocalizes and downregulates BRSK2, and a kinase-independent anti-apoptotic activity plus VCP/p97-associated ERAD function were proposed.\",\n      \"evidence\": \"Western blot, subcellular localization, knockdown/overexpression (WT and kinase-dead), co-IP and domain mapping with VCP/p97\",\n      \"pmids\": [\"22713462\", \"23907667\"],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"VCP/p97 link rests on single co-IP with indirect ERAD readout\", \"Kinase-independent anti-apoptotic mechanism unexplained\", \"Not independently confirmed\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Placed BRSK2 within nutrient and incretin signaling in \\u03b2-cells: glucose- and mTORC1-dependent translation controls SAD-A levels, and GLP-1/cAMP/Ca2+ activates it via relief of Thr443 autoinhibition, establishing it as required for GSIS and incretin action.\",\n      \"evidence\": \"Conditional/global knockout mice, glucose tolerance tests, rapamycin, 5'-UTR reporters, Thr443 mutagenesis, islet secretion assays\",\n      \"pmids\": [\"23922392\", \"23629625\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Kinase responsible for Thr443 phosphorylation not identified\", \"Link between mTORC1-driven translation and acute secretion timing unclear\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Defined a survival-promoting BRSK2 arm in cancer: BRSK2 phosphorylates TSC2 to suppress mTORC1 under nutrient deprivation, relieving feedback inhibition on Akt.\",\n      \"evidence\": \"Western blot for pTSC2/mTORC1 substrates, nutrient deprivation, overexpression/knockdown in PDAC cells\",\n      \"pmids\": [\"28591720\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct TSC2 phosphosite not mapped\", \"Single-lab; in vivo tumor relevance not tested\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Extended the \\u03b2-cell secretory mechanism: BRSK2 phosphorylates GDI\\u03b1 at Ser174 to release Rho GTPases and drives Bad Ser155 phosphorylation, coupling exocytosis to anti-apoptotic protection downstream of GLP-1.\",\n      \"evidence\": \"Co-IP, in vitro kinase/phosphorylation assay, shRNA, insulin secretion assays in INS-1 and primary islets; pBad-S155 blots and apoptosis assays\",\n      \"pmids\": [\"29873699\", \"30573363\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct Bad phosphorylation not confirmed by in vitro kinase assay\", \"Which Rho GTPases are mobilized downstream not delineated\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Established BRSK2's developmental role in vivo: Sada-/- mice show disorganized cortical lamination, delayed radial migration, and shortened axons, defining BRSK2 as essential for cortical neuron migration and polarization.\",\n      \"evidence\": \"Knockout mice, BrdU birthdating, in utero electroporation with time-lapse imaging, hippocampal neuron morphometry\",\n      \"pmids\": [\"30307479\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Substrates mediating migration/polarization in vivo not identified\", \"Relationship to presynaptic RIM1 function unresolved\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Connected BRSK2 kinase activity to redox and translational control: BRSK2 drives AMPK and suppresses mTOR, reducing protein synthesis and NRF2 levels.\",\n      \"evidence\": \"Gain-of-function kinase screen, phosphoproteomics, RNAseq, NRF2 reporter, kinase-dead controls\",\n      \"pmids\": [\"32546533\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct AMPK/mTOR-axis substrates of BRSK2 not pinpointed\", \"Single-lab activity-overexpression context\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Provided a chemical-biology tool: GW296115 was characterized as a potent, cell-active BRSK2 inhibitor enabling target engagement studies.\",\n      \"evidence\": \"KINOMEscan profiling of 403 kinases, cellular thermal shift assay, downstream phospho-westerns\",\n      \"pmids\": [\"32985588\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Off-target activity across the kinome not exhaustively excluded\", \"In vivo pharmacology not established\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Reframed BRSK2 in metabolic disease: lipid-induced BRSK2 stabilization drives kinase-dependent basal insulin hypersecretion, and \\u03b2-cell knockout protects from HFD-induced hyperinsulinemia and insulin resistance.\",\n      \"evidence\": \"Inducible \\u03b2-cell-specific knockout and gain-of-function mice, HFD feeding, kinase-dead mutant, insulin secretion assays\",\n      \"pmids\": [\"37188647\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular basis of lipid-induced BRSK2 stabilization not defined\", \"Lipid-sensing substrate(s) driving basal secretion not identified\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Linked BRSK2 to inflammatory signaling in cancer: BRSK2 phosphorylates PIMREG at Ser16 to promote its degradation and limit NF-\\u03baB, and its loss confers cisplatin resistance.\",\n      \"evidence\": \"miR-3960 overexpression, BRSK2 knockdown/rescue, Ser16-PIMREG phosphorylation and ubiquitination assays, NF-\\u03baB reporter, cisplatin resistance assays in TNBC\",\n      \"pmids\": [\"38582395\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"E3 ligase acting on PIMREG not identified\", \"Single-lab; direct kinase assay on PIMREG not shown\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Implicated BRSK2 in autophagy-driven cancer survival: endogenous BRSK2 associates with the Vps34-Beclin-1-ATG14 complex and sustains basal and stress autophagy plus AKT/STAT3/NF-\\u03baB survival signaling.\",\n      \"evidence\": \"Co-IP with autophagy complex components, siRNA, GW296115, autophagy flux and survival/metastasis assays\",\n      \"pmids\": [\"41258112\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether association is direct and which subunit is the kinase substrate unknown\", \"Single-lab co-IP without reciprocal structural validation\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How BRSK2's diverse substrate sets and contexts (presynaptic RIM1, \\u03b2-cell secretory machinery, mTOR/NRF2/NF-\\u03baB stress nodes, autophagy complex) are coordinated by upstream activation and degradation in a single integrated regulatory logic remains unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No unified model linking tissue-specific substrate selection to upstream LKB1/PKA/mTORC1 inputs\", \"Activation-loop phosphosite and full activation mechanism not consolidated\", \"In vivo substrate specificity in cancer contexts not established\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140096\", \"supporting_discovery_ids\": [0, 3, 4, 11, 12, 18]},\n      {\"term_id\": \"GO:0016740\", \"supporting_discovery_ids\": [0, 4, 12, 18]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [2, 8]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0031410\", \"supporting_discovery_ids\": [0]},\n      {\"term_id\": \"GO:0005815\", \"supporting_discovery_ids\": [6]},\n      {\"term_id\": \"GO:0005783\", \"supporting_discovery_ids\": [9]},\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [0]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-112316\", \"supporting_discovery_ids\": [0, 14]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [11, 15]},\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [14]},\n      {\"term_id\": \"R-HSA-9612973\", \"supporting_discovery_ids\": [19]},\n      {\"term_id\": \"R-HSA-1640170\", \"supporting_discovery_ids\": [6]},\n      {\"term_id\": \"R-HSA-392499\", \"supporting_discovery_ids\": [6, 7]}\n    ],\n    \"complexes\": [\"Vps34-Beclin-1-ATG14 autophagy complex\"],\n    \"partners\": [\"LKB1\", \"PRKACA\", \"CDK16\", \"PAK1\", \"GDI\\u03b1\", \"VCP\", \"JAB1/CSN5\", \"Beclin-1\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":6,"faith_total":6,"faith_pct":100.0}}